196 related articles for article (PubMed ID: 35545234)
21. Trimethoprim-sulfamethoxazole-induced hyponatremia in an elderly lady with Achromobacter xylosoxidans pneumonia: Case report and insights into mechanism.
Ghali MGZ; Kim MJ
Medicine (Baltimore); 2020 Aug; 99(33):e20746. PubMed ID: 32871970
[TBL] [Abstract][Full Text] [Related]
22. Hyperkalemia with high-dose trimethoprim-sulfamethoxazole therapy.
Greenberg S; Reiser IW; Chou SY
Am J Kidney Dis; 1993 Oct; 22(4):603-6. PubMed ID: 8213804
[TBL] [Abstract][Full Text] [Related]
23. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.
Alappan R; Perazella MA; Buller GK
Ann Intern Med; 1996 Feb; 124(3):316-20. PubMed ID: 8554227
[TBL] [Abstract][Full Text] [Related]
24. Dose-Dependent Hyperkalemia Among Hospitalized, HIV-Infected Patients Receiving Sulfamethoxazole/Trimethoprim.
Caulder CR; Kocherla CS; Qureshi ZP; Magagnoli J; Bookstaver PB
Ann Pharmacother; 2020 Sep; 54(9):852-857. PubMed ID: 32106685
[No Abstract] [Full Text] [Related]
25. Hyponatremia With Intravenous Sulfamethoxazole/Trimethoprim in Children.
Stephens K; Miller JL; Lewis TV; Neely S; Johnson PN
Ann Pharmacother; 2020 Apr; 54(4):351-358. PubMed ID: 31694388
[No Abstract] [Full Text] [Related]
26. Effect of trimethoprim-sulfamethoxazole on Na and K+ transport properties in the rabbit cortical collecting duct perfused in vitro.
Muto S; Tsuruoka S; Miyata Y; Fujimura A; Kusano E
Nephron Physiol; 2006; 102(3-4):p51-60. PubMed ID: 16286787
[TBL] [Abstract][Full Text] [Related]
27. Trimethoprim-associated hyponatremia.
Babayev R; Terner S; Chandra S; Radhakrishnan J; Mohan S
Am J Kidney Dis; 2013 Dec; 62(6):1188-92. PubMed ID: 23891358
[TBL] [Abstract][Full Text] [Related]
28. [Retrospective investigation of side effects and prognoses of moderate-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia that developed in patients with autoimmune diseases].
Shibata T; Tonooka K; Tsuchida K; Mitomi H; Shibata T; Katsuyama N
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):213-8. PubMed ID: 27320937
[TBL] [Abstract][Full Text] [Related]
29. Studies on the mechanism of trimethoprim-induced hyperkalemia.
Eiam-Ong S; Kurtzman NA; Sabatini S
Kidney Int; 1996 May; 49(5):1372-8. PubMed ID: 8731102
[TBL] [Abstract][Full Text] [Related]
30. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
[TBL] [Abstract][Full Text] [Related]
31. Risk factors associated with increased discontinuation rate of trimethoprim-sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study.
Otani T; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Iwamoto H; Hirata S; Fujitaka K; Hamada H; Sugiyama E; Hattori N
Pulm Pharmacol Ther; 2021 Apr; 67():101999. PubMed ID: 33571651
[TBL] [Abstract][Full Text] [Related]
32. Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study.
Weir MA; Juurlink DN; Gomes T; Mamdani M; Hackam DG; Jain AK; Garg AX
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1544-51. PubMed ID: 20595693
[TBL] [Abstract][Full Text] [Related]
33. [Factors contributing to increases in serum creatinine following treatment with a sulfamethoxazole-trimethoprim combination product: retrospective analysis of Japanese patients with normal renal function].
So M; Suzuki T; Takano K; Shimada K; Inoue M; Kawai T; Fukami T; Tomono K
Yakugaku Zasshi; 2013; 133(5):587-95. PubMed ID: 23649399
[TBL] [Abstract][Full Text] [Related]
34. Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome.
Mihm LB; Rathbun RC; Resman-Targoff BH
Pharmacotherapy; 1995; 15(6):793-7. PubMed ID: 8602391
[TBL] [Abstract][Full Text] [Related]
35. Effect of high-dose sulfamethoxazole/trimethoprim and glucocorticoid use on hyperkalemic event: A retrospective observational study.
Hirai T; Yamaga R; Ishikawa Y; Hanada K; Iwamoto T; Itoh T
J Infect Chemother; 2021 Nov; 27(11):1607-1613. PubMed ID: 34301486
[TBL] [Abstract][Full Text] [Related]
36. Renal mechanism of trimethoprim-induced hyperkalemia.
Velázquez H; Perazella MA; Wright FS; Ellison DH
Ann Intern Med; 1993 Aug; 119(4):296-301. PubMed ID: 8328738
[TBL] [Abstract][Full Text] [Related]
37. Hyponatraemia associated with trimethoprim use.
Khow KS; Yong TY
Curr Drug Saf; 2014 Mar; 9(1):79-82. PubMed ID: 24372181
[TBL] [Abstract][Full Text] [Related]
38. Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: Real-life data from a multicentre retrospective study.
Conan PL; Matignon M; Bleibtreu A; Guillot H; Van Laecke S; Brenier H; Crochette R; Melica G; Fernández-Ruiz M; Dantal J; Walti LN; Levi C; Chauvet C; De Greef J; Marbus SD; Mueller NJ; Ieven M; Vuotto F; Lortholary O; Coussement J; Lebeaux D
Transpl Infect Dis; 2021 Aug; 23(4):e13669. PubMed ID: 34143917
[TBL] [Abstract][Full Text] [Related]
39. Clinical use of trimethoprim/sulfamethoxazole during renal dysfunction.
Paap CM; Nahata MC
DICP; 1989 Sep; 23(9):646-54. PubMed ID: 2678767
[TBL] [Abstract][Full Text] [Related]
40. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
Chang HM; Tsai HC; Lee SS; Kunin C; Lin PC; Wann SR; Chen YS
J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
